Adynovate and Inotuzumab ozogamicin
Determining the interaction of Adynovate and Inotuzumab ozogamicin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Adynovate (recombinant)
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab Ozogamicin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Adynovate-Inotuzumab ozogamicin Intravenous
- Adynovate-Inova
- Adynovate-Inova 4/1 topical
- Adynovate-Inova 8/2 topical
- Adynovate-Inova ACT
- Adynovate-Inrebic
- Inotuzumab ozogamicin-Adynovate recombinant
- Inotuzumab ozogamicin-Adzenys ER
- Inotuzumab ozogamicin-Adzenys ER Oral Suspension
- Inotuzumab ozogamicin-Adzenys XR-ODT
- Inotuzumab ozogamicin-Aemcolo
- Inotuzumab ozogamicin-Aerobid